Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • Fox Chase Cancer Center

Aug 2008
Fox Chase Cancer Center of Philadelphia and VisEn Medical Inc. of Woburn, Mass., have partnered to advance the Phase I clinical trials of the company’s “smart” fluorescence-activatable imaging agents, which they hope will enable physicians to identify and characterize early-stage disease in oncology patients. The trials initially will focus on ovarian cancer and are scheduled to begin in 2009.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!